Home › Companies › EMERGENT BIOSOLUTIONS INC. › 2024-2025

EMERGENT BIOSOLUTIONS INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and EMERGENT BIOSOLUTIONS INC.’s Form 8-K, filed 2025-05-06 (Item 5.07 on EDGAR). Page generated 04 October 2026.

7Reported items
137Asset managers
592Fund votes
2025-04-30Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore EMERGENT BIOSOLUTIONS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by EMERGENT BIOSOLUTIONS INC.

These tallies are EMERGENT BIOSOLUTIONS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-05-06 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

EMERGENT BIOSOLUTIONS INC. — official shareholder meeting results, meeting held 2025-04-30
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Keith Katkin	21,684,528	--	--	1,094,567	13,361,713	Majority: yes
Elect Director: Ronald Richard	18,116,845	--	--	4,662,250	13,361,713	Majority: yes
Elect Director: Kathryn Zoon, Ph.D.	21,779,200	--	--	999,895	13,361,713	Majority: yes
Proposal 2: approved. The voting results were as follows:	34,773,959	1,152,704	214,145	--	--	Passed
Proposal 3: approved. The voting results were as follows:	18,928,777	3,537,501	312,817	--	13,361,713	Passed

Source: EMERGENT BIOSOLUTIONS INC., Form 8-K, filed with the SEC on 2025-05-06 — read the filing on EDGAR.

How asset managers voted at the EMERGENT BIOSOLUTIONS INC. 2024-2025 meeting

Each item below shows how the 137 asset managers that disclosed a EMERGENT BIOSOLUTIONS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of EMERGENT BIOSOLUTIONS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To Hold, On An Advisory Basis, A Vote To Approve The 2024 Compensation Of Our Named Executive Officers.

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-04-30.

Combines 3 wordings of this item as funds reported it.

86% fund support · no official result

FOR 85%14%

The 129 asset managers below cast 86% of the shares they voted on this item FOR (21,578,373 for, 3,490,993 against).

FOR: 21,578,373 (85.2%)AGAINST: 3,490,993 (13.8%)ABSTAIN: 247,595 (1.0%)NOT VOTED: 441 (0.0%)

Largest asset managers voting on “To Hold, On An Advisory Basis, A Vote To Approve The 2024 Compensation Of Our Named Executive Officers.” at EMERGENT BIOSOLUTIONS INC., 2024-2025
Asset manager	For	Against	Abstain	Vote
American Century	4,450,977	0	0	For
State Street	3,264,045	0	0	For
Vanguard	3,201,191	0	0	For
Charles Schwab	2,603,471	0	0	For
Dimensional	0	1,182,074	0	Against
OAK HILL ADVISORS LP	1,113,338	0	0	For
BlackRock	1,084,453	0	0	For
MARSHALL WACE, LLP	0	1,070,736	0	Against
Connor, Clark & Lunn Investment Management Ltd.	873,159	0	0	For
Fidelity	745,413	0	0	For
Renaissance	672,343	0	0	For
Two Sigma	643,747	0	0	For
PALISADE CAPITAL MANAGEMENT, LP	639,364	0	0	For
GEODE CAPITAL MANAGEMENT, LLC	597,618	0	0	For
Federated Hermes	0	516,639	0	Against
NEW YORK STATE COMMON RETIREMENT FUND	0	375,034	0	Against
Allspring	294,698	0	0	For
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.	0	0	210,000	Abstain
PARAMETRIC PORTFOLIO ASSOCIATES LLC	197,356	0	0	For
Citadel	184,295	0	0	For
FULLER & THALER ASSET MANAGEMENT, INC.	142,340	0	0	For
DE Shaw	103,888	0	0	For
Wellington	0	103,091	0	Against
Northern Trust	77,337	0	0	For
Direxion Shares ETF Trust	77,068	0	0	For

Showing the 25 largest of 129 asset managers. See all 129 in the interactive database.

2. To elect three Class I directors to hold office for a term expiring at our 2028 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Kathryn Zoon Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-04-30.

Combines 4 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 21,779,200WITHHELD: 999,895

EMERGENT BIOSOLUTIONS INC.’s own tally for this item (“Elect Director: Kathryn Zoon, Ph.D.”): 21,779,200 for, 999,895 withheld, per its Form 8-K filed 2025-05-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 54,500,000 outstanding shares: 40% for, 2% withheld (42% of the company cast a for/withheld vote).

The 35 asset managers below cast 100% of the shares they voted on this item FOR (10,879,895 for, 0 against).

FOR 100%

FOR: 10,879,895 (100.0%)

Largest asset managers voting on “To elect three Class I directors to hold office for a term expiring at our 2028 Annual Meeting of Stockholders” at EMERGENT BIOSOLUTIONS INC., 2024-2025
Asset manager	For	Vote
Vanguard	3,173,308	For
American Century	2,186,307	For
State Street	1,662,731	For
Charles Schwab	1,301,720	For
Dimensional	1,063,035	For
Fidelity	624,450	For
Federated Hermes	245,900	For
Allspring	131,492	For
Capitol Series Trust	96,715	For
Direxion Shares ETF Trust	77,068	For
BlackRock	61,670	For
Pacific Life	55,144	For
Harbor ETF Trust	36,404	For
ProShares	24,747	For
HUSSMAN INVESTMENT TRUST	21,000	For
Jackson National	12,361	For
T. Rowe Price	11,783	For
Blackstone Alternative Investment Funds	11,600	For
Equitable	10,077	For
Invesco	9,180	For
TRUST FOR PROFESSIONAL MANAGERS	8,944	For
Lincoln Financial	8,907	For
Northern Trust	8,439	For
Prudential/PGIM	7,370	For
Victory Capital	6,185	For

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

3. To elect three Class I directors to hold office for a term expiring at our 2028 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Keith Katkin

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-04-30.

Combines 3 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%

FOR: 21,684,528WITHHELD: 1,094,567

EMERGENT BIOSOLUTIONS INC.’s own tally for this item (“Elect Director: Keith Katkin”): 21,684,528 for, 1,094,567 withheld, per its Form 8-K filed 2025-05-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 54,500,000 outstanding shares: 40% for, 2% withheld (42% of the company cast a for/withheld vote).

The 35 asset managers below cast 100% of the shares they voted on this item FOR (10,633,995 for, 0 against).

FOR 98%

FOR: 10,633,995 (97.7%)ABSTAIN: 245,900 (2.3%)

Largest asset managers voting on “To elect three Class I directors to hold office for a term expiring at our 2028 Annual Meeting of Stockholders” at EMERGENT BIOSOLUTIONS INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	3,173,308	0	For
American Century	2,186,307	0	For
State Street	1,662,731	0	For
Charles Schwab	1,301,720	0	For
Dimensional	1,063,035	0	For
Fidelity	624,450	0	For
Federated Hermes	0	245,900	Abstain
Allspring	131,492	0	For
Capitol Series Trust	96,715	0	For
Direxion Shares ETF Trust	77,068	0	For
BlackRock	61,670	0	For
Pacific Life	55,144	0	For
Harbor ETF Trust	36,404	0	For
ProShares	24,747	0	For
HUSSMAN INVESTMENT TRUST	21,000	0	For
Jackson National	12,361	0	For
T. Rowe Price	11,783	0	For
Blackstone Alternative Investment Funds	11,600	0	For
Equitable	10,077	0	For
Invesco	9,180	0	For
TRUST FOR PROFESSIONAL MANAGERS	8,944	0	For
Lincoln Financial	8,907	0	For
Northern Trust	8,439	0	For
Prudential/PGIM	7,370	0	For
Victory Capital	6,185	0	For

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

4. To elect three Class I directors to hold office for a term expiring at our 2028 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Ronald Richard

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-04-30.

Combines 3 wordings of this item as funds reported it.

80% Majority: yes · of votes cast

FOR 80%WITHHELD 20%

FOR: 18,116,845WITHHELD: 4,662,250

EMERGENT BIOSOLUTIONS INC.’s own tally for this item (“Elect Director: Ronald Richard”): 18,116,845 for, 4,662,250 withheld, per its Form 8-K filed 2025-05-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 54,500,000 outstanding shares: 33% for, 9% withheld (42% of the company cast a for/withheld vote).

The 35 asset managers below cast 100% of the shares they voted on this item FOR (9,081,350 for, 0 against).

FOR 83%ABSTAIN 17%

FOR: 9,081,350 (83.5%)ABSTAIN: 1,798,545 (16.5%)

Largest asset managers voting on “To elect three Class I directors to hold office for a term expiring at our 2028 Annual Meeting of Stockholders” at EMERGENT BIOSOLUTIONS INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	3,173,308	0	For
American Century	2,186,307	0	For
State Street	128,161	1,534,570	Abstain
Charles Schwab	1,301,720	0	For
Dimensional	1,063,035	0	For
Fidelity	624,450	0	For
Federated Hermes	0	245,900	Abstain
Allspring	131,492	0	For
Capitol Series Trust	96,715	0	For
Direxion Shares ETF Trust	77,068	0	For
BlackRock	61,670	0	For
Pacific Life	55,144	0	For
Harbor ETF Trust	36,404	0	For
ProShares	24,747	0	For
HUSSMAN INVESTMENT TRUST	21,000	0	For
Jackson National	12,361	0	For
T. Rowe Price	11,783	0	For
Blackstone Alternative Investment Funds	11,600	0	For
Equitable	10,077	0	For
Invesco	0	9,180	Abstain
TRUST FOR PROFESSIONAL MANAGERS	8,944	0	For
Lincoln Financial	8,907	0	For
Northern Trust	0	8,439	Abstain
Prudential/PGIM	7,370	0	For
Victory Capital	6,185	0	For

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

5. To Ratify The Appointment Of Ernst & Young LLP As Our Independent Registered Public Accounting Firm For The Fiscal Year Ending December 31, 2025.

AUDIT-RELATED

Meeting held 2025-04-30.

99.9% fund support · no official result

FOR 99.9%

The 35 asset managers below cast 99.9% of the shares they voted on this item FOR (10,879,378 for, 517 against).

FOR: 10,879,378 (100.0%)AGAINST: 517 (0.0%)

Largest asset managers voting on “To Ratify The Appointment Of Ernst & Young LLP As Our Independent Registered Public Accounting Firm For The Fi” at EMERGENT BIOSOLUTIONS INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	3,173,308	0	For
American Century	2,186,307	0	For
State Street	1,662,670	61	For
Charles Schwab	1,301,720	0	For
Dimensional	1,063,035	0	For
Fidelity	624,450	0	For
Federated Hermes	245,900	0	For
Allspring	131,492	0	For
Capitol Series Trust	96,715	0	For
Direxion Shares ETF Trust	77,068	0	For
BlackRock	61,670	0	For
Pacific Life	55,144	0	For
Harbor ETF Trust	36,404	0	For
ProShares	24,747	0	For
HUSSMAN INVESTMENT TRUST	21,000	0	For
Jackson National	12,361	0	For
T. Rowe Price	11,783	0	For
Blackstone Alternative Investment Funds	11,600	0	For
Equitable	10,077	0	For
Invesco	9,180	0	For
TRUST FOR PROFESSIONAL MANAGERS	8,944	0	For
Lincoln Financial	8,907	0	For
Northern Trust	8,439	0	For
Prudential/PGIM	7,370	0	For
Victory Capital	6,185	0	For

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

6. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-04-30.

93% fund support · no official result

FOR 93%7%

The 3 asset managers below cast 93% of the shares they voted on this item FOR (325 for, 25 against).

FOR: 325 (92.9%)AGAINST: 25 (7.1%)

Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at EMERGENT BIOSOLUTIONS INC., 2024-2025
Asset manager	For	Against	Vote
BEACON INVESTMENT ADVISORY SERVICES, INC.	200	0	For
TD Waterhouse Canada Inc.	125	0	For
Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma	0	25	Against

7. To hold, on an advisory basis, a vote to approve the 2023 compensation of our named executive officers;

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2024-05-23 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (1,848 for, 0 against).

FOR: 1,848 (100.0%)

Largest asset managers voting on “To hold, on an advisory basis, a vote to approve the 2023 compensation of our named executive officers;” at EMERGENT BIOSOLUTIONS INC., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
VAUGHAN DAVID INVESTMENTS LLC/IL	1,000	0	0	0	For
COLDSTREAM CAPITAL MANAGEMENT INC	848	0	0	0	For

Largest EMERGENT BIOSOLUTIONS INC. shareholders voting in 2024-2025

Ranked by the number of EMERGENT BIOSOLUTIONS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 54,500,000 shares outstanding at the time of that meeting.

Top EMERGENT BIOSOLUTIONS INC. shareholders by shares voted, 2024-2025
#	Asset manager	% of shares outstanding
1	American Century	8.17%
2	State Street	5.99%
3	Vanguard	5.87%
4	Charles Schwab	4.78%
5	Dimensional	2.17%
6	OAK HILL ADVISORS LP	2.04%
7	BlackRock	1.99%
8	MARSHALL WACE, LLP	1.96%
9	Connor, Clark & Lunn Investment Management Ltd.	1.60%
10	Fidelity	1.37%

Reported EMERGENT BIOSOLUTIONS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

EMERGENT BIOSOLUTIONS INC. beneficial owners on record for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
Oak Hill Advisors, L.P.	6.63%	DEF14A
Vanguard Group	5.90%	13F
BlackRock	3.37%	13F
State Street	3.14%	13F
Dimensional Fund Advisors	2.93%	13F
Goldman Sachs	2.00%	13F
Morgan Stanley	1.59%	13F
Renaissance Technologies	1.39%	13F
Joseph Papa	1.38%	DEF14A
Invesco	1.37%	13F

Percentages above are of 54,500,000 shares outstanding, as reported by EMERGENT BIOSOLUTIONS INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from EMERGENT BIOSOLUTIONS INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At EMERGENT BIOSOLUTIONS INC.'s shareholder meeting held 2025-04-30, in the 2024-2025 proxy season, 137 asset managers reported how they voted in their SEC Form N-PX filings, covering 592 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. EMERGENT BIOSOLUTIONS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To Hold, On An Advisory Basis, A Vote To Approve The 2024 Compensation Of Our Named Executive… — the reporting funds cast 86% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

EMERGENT BIOSOLUTIONS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.